首页> 外国专利> Rational drug design targeting resistant gram-negative bacterial infections against polymyxin antibiotics

Rational drug design targeting resistant gram-negative bacterial infections against polymyxin antibiotics

机译:针对多粘菌素抗生素耐药的革兰氏阴性细菌感染的合理药物设计

摘要

The present invention relates to the identification and composition of aminoarabinase glycosyltransferase (ArnT) inhibitors or antagonists, methods of treating or preventing drug-resistant gram-negative infections, or gram-negative bacterial infections resistant to polymyxin antibiotics. It relates to their use in inhibiting increase. In certain embodiments, the inhibitor or antagonist can be administered in combination with one or more antibacterial agents. [Selection] Figure 1A
机译:本发明涉及氨基阿拉伯糖苷酶糖基转移酶(ArnT)抑制剂或拮抗剂的鉴定和组成,治疗或预防对多粘菌素抗生素有抗药性的革兰氏阴性感染或革兰氏阴性细菌感染的方法。它涉及它们在抑制增加中的用途。在某些实施方案中,抑制剂或拮抗剂可以与一种或多种抗菌剂组合施用。 [选型]图1A

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号